Sheel Biotech was incorporated on November 26, 1991. The company specialises in growing, processing, and supplying plants for crops, fruits, vegetables, and ornamentals through tissue culture and organic farming, while providing greenhouse solutions, farmer training, and landscaping services. ISO-certified and led by industry experts, it operates an R&D lab with a 10 million planting material capacity, recognised by India’s Department of Biotechnology
| Bidding Dates |
|---|
| 30 Sep 2025 - 03 Oct 2025 |
| Subscription |
|---|
| 14.93x Oversubscribed |
| Minimum Investment | Minimum Lot | Maximum Lot | Lot Size | Number of Shares | Issue Price Band | Post Issue Promoter Holding % | Issue Size | IPO Document |
|---|---|---|---|---|---|---|---|---|
| ₹2,36,000 | 2 | 2 | 2000 | 5.4 M | ₹59 - ₹63 | 71.26 % | ₹318.6 M - ₹340.2 M | RHP DOC |
Sheel Biotech IPO SUBSCRIPTION STATUS
03 Oct '25Sheel Biotech IPO overall subscription rate was 14.93 times the total available shares
Sheel Biotech IPO retail subscription rate was 12.72 times in the retail segment
Sheel Biotech IPO non-institutional investor subscription rate was 35.01 times in the non-institutional investor category
Sheel Biotech IPO Qualified Institutional Bidder subscription rate was 10.45 times the available shares for Qualified Institutional Bidder
| Day | Retail Individual Investor | HNI (NII) Investors | Qualified Institutional Buyers |
|---|---|---|---|
| Category Reservation | 35% | 15% | 50% |
03 Oct 2025 (Day 3) | 12.72x | 35.01x | 10.45x |
01 Oct 2025 (Day 2) | 0.69x | 0.66x | 0.01x |
30 Sep 2025 (Day 1) | 0.07x | 0.13x | - |
Sheel Biotech FINANCIALS
| Period | Revenue from Operations (Rs in crore) | Net Profit (Rs in crore) | Cash Flow from Operations (Rs in crore) | Free Cash Flow (Rs in crore) | Margins |
| FY25 | 101.8 | 10.6 | 9.2 | 8.2 | 14.7% |
| FY24 | 92.3 | 10.5 | -0.9 | -1.2 | 15.7% |
| FY23 | 80.1 | 5.1 | 9.3 | 8.1 | 11.0% |
Sheel Biotech IPO SUBSCRIPTION STATUS DETAILS
Sheel Biotech had 5.4 M shares on offer
Sheel Biotech IPO offer price was in the range ₹59 - ₹63
Sheel Biotech IPO minimum Investment was ₹236000
Sheel Biotech IPO issue size was ₹ 318.6 M - ₹ 340.2 M
Sheel Biotech had a minimum lot size of 2000 Shares per application
Sheel Biotech NUMBER OF SHARES ON OFFER
Sheel Biotech IPO IMPORTANT DATES
| Issue Open Date | 30 Sep 2025 |
| Issue close Date | 03 Oct 2025 |
| Allotment Date | 06 Oct 2025 |
| Refund Date | 07 Oct 2025 |
| Demat Account Credit Date | 07 Oct 2025 |
| Listing Date | 08 Oct 2025 |
| Listing on Exchange(s) | NSE |
| Sheel Biotech Allotment Status | Exchange/ Registrar |
Sheel Biotech IPO subscription opened on 30 Sep 2025, and closed on 03 Oct 2025
IPO allotment for Sheel Biotech was finalized on Monday, 06 Oct 2025
IPO listing for Sheel Biotech was on NSE on Wednesday, 08 Oct 2025
Sheel Biotech IPO LISTING GAINS
| Issue Price (adjusted) | 63.0 |
| Listing Open Price | 91.0 |
| Listing Close Price | 95.5 |
| Listing Gain% | 44.4% |
| Current Gain% | 3.3% |
Sheel Biotech Peer
| Stock | Stock Price | Market Cap (Rs crore) | PE TTM | PEG TTM | PS TTM | ROE% | ROA% | Annual Revenue (Rs crore) | Annual Revenue Growth % | Annual Net Profit (Rs crore) | Annual Net Profit Growth % | EPS TTM | EPS TTM Growth % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sheel Biotech Ltd. | 65.1 | 132.5 | 11.3 | 1.1 | 1.2 | 9.2 | 8.1 | 110.7 | 8.3 | 11.8 | 10.5 | 5.8 | 10.5 |
| Sagility Ltd. | 43.7 | 20443.4 | 20.6 | 0.4 | 2.7 | 9.6 | 7.3 | 7290.8 | 29.6 | 924.8 | 71.5 | 2.1 | 49.2 |
| International Gemological Institute Ltd. | 355.8 | 15376.2 | 25.2 | 1 | 11.3 | 47.8 | 38.3 | 1661.9 | 52.7 | 711.2 | 66.4 | 14.1 | 24.3 |
| Indiabulls Ltd. | 29.4 | 6855.8 | 16.4 | 0 | 6.2 | 8.9 | 6.6 | 880.8 | 172602 | 273.9 | 501.6 | 1.8 | 739.2 |
| SIS Ltd. | 435 | 6146.2 | 41.9 | 0.2 | 0.4 | 5.4 | 1.8 | 16030.1 | 20.9 | 137.8 | 1069.1 | 10.4 | 261.6 |
| eMudhra Ltd. | 538.8 | 4462.3 | 38.8 | 1.5 | 6 | 11.8 | 8.9 | 713.2 | 35.1 | 107.8 | 27.4 | 13.9 | 25.5 |
Sheel Biotech INFORMATION ON IPO ISSUE
About Sheel Biotech
Sheel Biotech was incorporated on November 26, 1991. The company specialises in growing, processing, and supplying plants for crops, fruits, vegetables, and ornamentals through tissue culture and organic farming, while providing greenhouse solutions, farmer training, and landscaping services. ISO-certified and led by industry experts, it operates an R&D lab with a 10 million planting material capacity, recognised by India’s Department of Biotechnology
Object of the Issue
- To meet the capital expenditure requirements of the company
- To meet out the expenses for working capital requirement for the company
- To meet out the expenses for general corporate purpose
Sheel Biotech - PROMOTERS
| Name |
|---|
| Satya Narayan Chandak |
| Sanjay Chandak |
| Divye Chandak |
| Mini Chadha |
| Satya Narayan Chandak (HUF) |
| Sumeet Chandak (HUF) |
| Sanjay Chandak (HUF) |
Sheel Biotech - MANAGEMENT & LEADERSHIP
| Name | Designation |
|---|---|
| Satya Narayan Chandak | Chairman & Director |
| Sanjay Chandak | Director |
| Divye Chandak | Managing Director |
| Mini Chadha | Director |
| Ramesh Chandra Srivastava | Independent Director |
| Shyamsundar Bang | Independent Director |
| Atul Kumar | Independent Director |
Sheel Biotech Book Running Lead Manager
Narnolia Financial Services Limited
pankaj.passi@narnolia.com
Sheel Biotech Registrar to the issue
Skyline Financial Services Private Limited
compliances@skylinerta.com
Sheel Biotech Strengths
Expertise in sustainable agriculture
The company has unique expertise in biotechnology, organic farming, and greenhouse management. It offers diverse products across agriculture, floriculture, and horticulture, with a strong focus on sustainable and eco-friendly practices
Market linkages & sales
The company researches markets to identify buyers, understand trends, and set prices, using direct sales channels, retail partnerships, and online platforms. It manages contract farming and explores export opportunities while ensuring compliance with regulations
Sheel Biotech Risks
Risk of contamination
The company follows proper tissue culture techniques, but ineffective sterilisation of tools or media can cause contamination, affecting plant growth and operations. While no such incidents have occurred, future occurrences cannot be fully ruled out
Dependent on government tenders
In the organic farming segment, the company relies heavily on government tenders for revenue. Failure to secure these tenders in the future could adversely impact business operations and financial performance
Weather & seasonal risks
The company’s operations are affected by seasonal and extreme weather conditions like heavy rains, floods, or cyclones, which can disrupt projects and damage equipment and premises. Such events may also force suspension of activities, impacting agricultural and landscaping operations
IPO FAQs
The promoters of the company are Satya Narayan Chandak, Sanjay Chandak, Divye Chandak, Mini Chadha, Satya Narayan Chandak (HUF), Sumeet Chandak (HUF) and Sanjay Chandak (HUF).
The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.
The price band of the IPO is Rs 59.0 - 63.0.
The IPO application opens on Sep 30, 2025 and closes on Oct 03, 2025.
The minimum lot size for the IPO is 4000. The maximum lot size for the IPO is 4000.
For all category investors, the minimum application amount for this IPO is Rs. 236,000.0, the maximum value for this IPO is Rs 252,000.0.
This IPO will be allotted on Oct 06, 2025.
The refund will be credited to your account on Oct 07, 2025.
The allotted shares will be credited to your demat on Oct 07, 2025.
Sheel Biotech Ltd.’s shares listed on the stock exchanges on Oct 08, 2025.